• Mashup Score: 2

    MONDAY, June 2, 2025 (HealthDay News) — A culturally tailored intervention for Latina breast cancer survivors (BCSs) yields clinically relevant but not statistically significant improvement in anxiety and fatigue compared with usual services, according to a study published online June 2 in Cancer. Katarina E. AuBuchon, Ph.D., from the Lombardi Comprehensive Cancer Center at Georgetown

    Tweet Tweets with this article
    • A recent randomized controlled trial published in @JournalCancer assessed the benefits of a culturally tailored intervention for Latina #BreastCancer survivors and their caregivers. @physicianswkly covers the findings here: https://t.co/6YPYy070p6 @ACS_Research @gumedcenter

  • Mashup Score: 0

    Chronic Diseases and Translational Medicine is a global journal committed to advancing the prevention, diagnosis, and treatment of chronic conditions.

    Tweet Tweets with this article
    • Discover the latest themed collections on cutting-edge research topics from Chronic Diseases and Translational Medicine! Dive into curated articles that drive innovation and knowledge in your field. ➡️Explore now: https://t.co/xiAw0KSGS2 #ChronicDiseases #openaccess https://t.co/INtypkpSiK

  • Mashup Score: 3

    Background Radiopharmaceutical therapy (RPT) has gained notable attention for its potential in treating difficult cancers, with [177Lu]Lu-DOTATATE being a notable example. However, the radiobiology …

    Tweet Tweets with this article
    • Read now: A novel fast strategy to calculate equieffective doses under different dose rate conditions (by Mark J. Macsuka et al.), an #OpenAccess Editor's Choice article from #MedicalPhysics and @aapmHQ. https://t.co/0jtTnIKQPu https://t.co/JagMFq8G8t

  • Mashup Score: 1

    Keep these five common English grammar mistakes in mind when proofreading your work

    Tweet Tweets with this article
    • You've probably made these grammar mistakes. ❌ Avoid them next time with the help of our free tip sheet. #ResearcherTips Get your copy now 🔗 https://t.co/bbpKu74QND https://t.co/PRFccx6DeE